EUVIMEDEUVIMED entdecken
Crossref

Persistent left superior vena cava isolation in patients with atrial fibrillation: Selective or empirical?

Jianquan Chen, Yue Qiu, Hongwu Chen, Caiyi Jin, Yuxuan Wang, Weizhu Ju, Gang Yang, Kai Gu, Hailei Liu, Zidun Wang, Xiaohong Jiang, Mingfang Li iD und 2 weitere

Pacing and Clinical Electrophysiology · 2023

DOI: 10.1111/pace.14872 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pacing and Clinical Electrophysiology, 2023. Verfasst von Jianquan Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Atrial Fibrillation, Persistent Left Superior Vena Cava, Catheter Ablation, Tachycardia, Supraventricular. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Persistent left superior vena cava (PLSVC) is the most prevalent form of thoracic venous abnormality and can serve as a significant arrhythmogenic source in atrial fibrillation (AF). Methods and results Among the 3950 patients who underwent radiofrequency ablation for AF between September 2014 to April 2020, 17 patients (mean age 59.4 ± 8.0 years, 64.7% male) with PLSVC were identified. Among them, nine patients (52.9%) had a prior history of pulmonary vein isolation (PVI) alone. Eight out of nine patients who experienced AF recurrence underwent PLSVC isolation with or without pulmonary vein (PV) reconnection. For the remaining eight patients (47.1%), PVI plus PLSVC isolation were performed during the index procedure. Ectopy originating from PLSVC was documented in 11 patients (64.7%) and successful PLSVC isolation was achieved in 16 patients (94.1%). After a median follow‐up of 28.3 months, freedom from AF/ atrial tachycardia (AT) was observed in 13 patients (76.5%).

Conclusion

Empirical PLSVC isolation beyond PVI appears to be a feasible and safe strategy to prevent AF recurrence in patients with concomitant PLSVC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationPersistent Left Superior Vena CavaCatheter AblationTachycardia, SupraventricularPulmonary VeinsHumansMaleMiddle AgedAgedFemaleVena Cava, SuperiorRecurrenceTreatment Outcome

Stichwörter der Autor:innen

atrial fibrillationcatheter ablationpersistent left superior vena cavapulmonary veins

Autor:innen und Institutionen

  • Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

ORCID-Profile: Mingfang Li, Minglong Chen

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, J., Qiu, Y., Chen, H., Jin, C., Wang, Y., Ju, W., Yang, G., Gu, K., Liu, H., Wang, Z., Jiang, X., Li, M., Wang, D., & Chen, M. (2023). Persistent left superior vena cava isolation in patients with atrial fibrillation: Selective or empirical?. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.14872

Vancouver

Chen J, Qiu Y, Chen H, Jin C, Wang Y, Ju W, et al. Persistent left superior vena cava isolation in patients with atrial fibrillation: Selective or empirical?. Pacing and Clinical Electrophysiology. 2023. doi:10.1111/pace.14872

BibTeX
@article{Chen2023,
  author = {Chen, Jianquan and Qiu, Yue and Chen, Hongwu and Jin, Caiyi and Wang, Yuxuan and Ju, Weizhu and Yang, Gang and Gu, Kai and Liu, Hailei and Wang, Zidun and Jiang, Xiaohong and Li, Mingfang and Wang, Daowu and Chen, Minglong},
  title = {Persistent left superior vena cava isolation in patients with atrial fibrillation: Selective or empirical?},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2023},
  doi = {10.1111/pace.14872}
}
Kostenlos starten →